346 related articles for article (PubMed ID: 15062854)
1. Functional analysis of the regulatory regions of the matrilin-1 gene in transgenic mice reveals modular arrangement of tissue-specific control elements.
Karcagi I; Rauch T; Hiripi L; Rentsendorj O; Nagy A; Bõsze Z; Kiss I
Matrix Biol; 2004 Feb; 22(8):605-18. PubMed ID: 15062854
[TBL] [Abstract][Full Text] [Related]
2. Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene.
Rentsendorj O; Nagy A; Sinkó I; Daraba A; Barta E; Kiss I
Biochem J; 2005 Aug; 389(Pt 3):705-16. PubMed ID: 15804237
[TBL] [Abstract][Full Text] [Related]
3. Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice.
Higashibata Y; Sakuma T; Kawahata H; Fujihara S; Moriyama K; Okada A; Yasui T; Kohri K; Kitamura Y; Nomura S
J Bone Miner Res; 2004 Jan; 19(1):78-88. PubMed ID: 14753740
[TBL] [Abstract][Full Text] [Related]
4. In vivo human Cartilage oligomeric matrix protein (COMP) promoter activity.
Posey KL; Davies S; Bales ES; Haynes R; Sandell LJ; Hecht JT
Matrix Biol; 2005 Dec; 24(8):539-49. PubMed ID: 16214313
[TBL] [Abstract][Full Text] [Related]
5. Expression of the cartilage matrix protein gene at different chondrocyte developmental stages.
Muratoglu S; Bachrati C; Malpeli M; Szabó P; Neri M; Dozin B; Deák F; Cancedda R; Kiss I
Eur J Cell Biol; 1995 Dec; 68(4):411-8. PubMed ID: 8690020
[TBL] [Abstract][Full Text] [Related]
6. Long-range upstream and downstream enhancers control distinct subsets of the complex spatiotemporal Sox9 expression pattern.
Bagheri-Fam S; Barrionuevo F; Dohrmann U; Günther T; Schüle R; Kemler R; Mallo M; Kanzler B; Scherer G
Dev Biol; 2006 Mar; 291(2):382-97. PubMed ID: 16458883
[TBL] [Abstract][Full Text] [Related]
7. The specificity of the myelin basic protein gene promoter studied in transgenic mice.
Asipu A; Mellor AL; Blair GE
Biochem Biophys Res Commun; 2001 Nov; 288(4):809-18. PubMed ID: 11688980
[TBL] [Abstract][Full Text] [Related]
8. Mice lacking matrilin-1 (cartilage matrix protein) have alterations in type II collagen fibrillogenesis and fibril organization.
Huang X; Birk DE; Goetinck PF
Dev Dyn; 1999 Dec; 216(4-5):434-41. PubMed ID: 10633862
[TBL] [Abstract][Full Text] [Related]
9. Osteoblast-specific expression of the alpha 2(I) collagen promoter in transgenic mice: correlation with the distribution of TGF-beta 1.
D'Souza RN; Niederreither K; de Crombrugghe B
J Bone Miner Res; 1993 Sep; 8(9):1127-36. PubMed ID: 8237483
[TBL] [Abstract][Full Text] [Related]
10. Novel pre- and post-gastrulation expression of Gata4 within cells of the inner cell mass and migratory neural crest cells.
Pilon N; Raiwet D; Viger RS; Silversides DW
Dev Dyn; 2008 Apr; 237(4):1133-43. PubMed ID: 18351674
[TBL] [Abstract][Full Text] [Related]
11. Neural and skin cell-specific expression pattern conferred by steel factor regulatory sequence in transgenic mice.
Yoshida H; Hayashi S; Shultz LD; Yamamura K; Nishikawa S; Nishikawa S; Kunisada T
Dev Dyn; 1996 Oct; 207(2):222-32. PubMed ID: 8906425
[TBL] [Abstract][Full Text] [Related]
12. Chick delta1-crystallin enhancer influences mouse alphaA-crystallin promoter activity in transgenic mice.
Reneker LW; Chen Q; Bloch A; Xie L; Schuster G; Overbeek PA
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4083-90. PubMed ID: 15505059
[TBL] [Abstract][Full Text] [Related]
13. Developmental expression of a type II collagen/beta-galactosidase fusion gene in transgenic mice.
Metsäranta M; Garofalo S; Smith C; Niederreither K; de Crombrugghe B; Vuorio E
Dev Dyn; 1995 Oct; 204(2):202-10. PubMed ID: 8589444
[TBL] [Abstract][Full Text] [Related]
14. Regulatory elements of Xenopus col2a1 drive cartilaginous gene expression in transgenic frogs.
Kerney R; Hall BK; Hanken J
Int J Dev Biol; 2010; 54(1):141-50. PubMed ID: 19757383
[TBL] [Abstract][Full Text] [Related]
15. A promoter element of the CD-RAP gene is required for repression of gene expression in non-cartilage tissues in vitro and in vivo.
Okazaki K; Yu H; Davies SR; Imamura T; Sandell LJ
J Cell Biochem; 2006 Mar; 97(4):857-68. PubMed ID: 16250001
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of mouse 3-phosphoglycerate dehydrogenase (Phgdh) gene promoter in developing brain.
Shimizu M; Furuya S; Shinoda Y; Mitoma J; Okamura T; Miyoshi I; Kasai N; Hirabayashi Y; Suzuki Y
J Neurosci Res; 2004 Jun; 76(5):623-32. PubMed ID: 15139021
[TBL] [Abstract][Full Text] [Related]
17. Temporal and spatial regulation of gene expression mediated by the promoter for the human tissue inhibitor of metalloproteinases-3 (TIMP-3)-encoding gene.
Zeng Y; Rosborough RC; Li Y; Gupta AR; Bennett J
Dev Dyn; 1998 Mar; 211(3):228-37. PubMed ID: 9520110
[TBL] [Abstract][Full Text] [Related]
18. Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX.
Budde B; Blumbach K; Ylöstalo J; Zaucke F; Ehlen HW; Wagener R; Ala-Kokko L; Paulsson M; Bruckner P; Grässel S
Mol Cell Biol; 2005 Dec; 25(23):10465-78. PubMed ID: 16287859
[TBL] [Abstract][Full Text] [Related]
19. Analysis of regulatory elements of E-cadherin with reporter gene constructs in transgenic mouse embryos.
Stemmler MP; Hecht A; Kinzel B; Kemler R
Dev Dyn; 2003 Jun; 227(2):238-45. PubMed ID: 12761851
[TBL] [Abstract][Full Text] [Related]
20. Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.
Kwon DN; Choi YJ; Park JY; Cho SK; Kim MO; Lee HT; Kim JH
J Cell Biochem; 2006 Oct; 99(2):462-77. PubMed ID: 16619260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
